5-(6-(but-2-en-1-yl)-2-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-2-(morpholine-4-carbonyl)benzonitrile

ID: ALA5268936

Max Phase: Preclinical

Molecular Formula: C24H24N4O3

Molecular Weight: 416.48

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)c(C#N)c2)c2cc(C)[nH]c2c1=O

Standard InChI:  InChI=1S/C24H24N4O3/c1-3-4-7-28-15-21(20-12-16(2)26-22(20)24(28)30)17-5-6-19(18(13-17)14-25)23(29)27-8-10-31-11-9-27/h3-6,12-13,15,26H,7-11H2,1-2H3/b4-3+

Standard InChI Key:  BQAKOVGAYWUDIT-ONEGZZNKSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
   -0.3340    2.4741    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3805    2.8864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0924    2.4745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0924    1.6493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3823    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3340    1.6456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3823    0.4122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0969   -0.0005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0961   -0.8233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3813   -1.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3306   -0.8268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3353   -0.0020    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3813   -2.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0959   -2.4738    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3333   -2.4738    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3333   -3.2990    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480   -3.7116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7626   -3.2990    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7626   -2.4738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0480   -2.0612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8754    1.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3674    2.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8966    2.7247    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3805    3.7116    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0487    2.8867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7634    2.4741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4780    2.8867    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1927    2.4741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1927    2.0710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8108   -1.2358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5255   -1.6485    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  7  5  1  0
  8  7  2  0
  9  8  1  0
 10  9  2  0
 11 10  1  0
 12 11  2  0
  7 12  1  0
 10 13  1  0
 13 14  2  0
 13 15  1  0
 16 15  1  0
 17 16  1  0
 18 17  1  0
 19 18  1  0
 20 19  1  0
 15 20  1  0
  4 21  1  0
 21 22  2  0
 23 22  1  0
  3 23  1  0
  2 24  2  0
  1 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 22 29  1  0
  9 30  1  0
 30 31  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5268936

    ---

Associated Targets(Human)

BRD9 Tchem Bromodomain-containing protein 9 (684 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRD4 Tchem Bromodomain-containing protein 4 (13122 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CECR2 Tchem Cat eye syndrome critical region protein 2 (340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TAF1 Tchem Transcription initiation factor TFIID subunit 1 (441 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 416.48Molecular Weight (Monoisotopic): 416.1848AlogP: 3.23#Rotatable Bonds: 4
Polar Surface Area: 91.12Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 12.85CX Basic pKa: CX LogP: 2.23CX LogD: 2.23
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.66Np Likeness Score: -1.06

References

1. Crawford TD, Vartanian S, Côté A, Bellon S, Duplessis M, Flynn EM, Hewitt M, Huang HR, Kiefer JR, Murray J, Nasveschuk CG, Pardo E, Romero FA, Sandy P, Tang Y, Taylor AM, Tsui V, Wang J, Wang S, Zawadzke L, Albrecht BK, Magnuson SR, Cochran AG, Stokoe D..  (2017)  Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance.,  27  (15): [PMID:28606761] [10.1016/j.bmcl.2017.05.063]

Source